<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02885428</url>
  </required_header>
  <id_info>
    <org_study_id>2014-A01458-39</org_study_id>
    <nct_id>NCT02885428</nct_id>
  </id_info>
  <brief_title>Detection no Invasive of a Silent Myocardial Ischemia</brief_title>
  <official_title>Silent Myocardial Ischemia in Patients With Diabetes Type 2: Diagnostic Value of Myocardial Strains Left Ventricular Resting Echocardiography 2D and 3D, Compared to Stress Echocardiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The pathophysiological features of myocardial diabetic subject combined with cardiac&#xD;
      autonomic neuropathy were behind the quietness of myocardial ischemia, known as silent&#xD;
      myocardial ischemia (IMS). These patients have the risk to remain asymptomatic until the&#xD;
      sudden onset of a myocardial infarction, or even sudden death.&#xD;
&#xD;
      That is why the investigators want to evaluate the contribution of non-invasive tools to&#xD;
      stand in the diagnosis of IMS patients with diabetes type 2, asymptomatic heart on map:&#xD;
      Technical myocardial speckle tracking in studying strains overall average left ventricular&#xD;
      (longitudinal, circumferential and radial) measured in 2D and 3D at rest, compared to stress&#xD;
      echocardiography with dobutamine (ESD)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>diagnostic of the silent myocardial ischemia</measure>
    <time_frame>80 minutes</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Silent Myocardial Ischemia</condition>
  <condition>Type 2 Diabetes</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>echography</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with type 2 diabetes, men or women, asymptomatic on the heart level, high risk&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  With at least two cardiovascular risk factors including: hypertension, dyslipidemia,&#xD;
             smoking active or interrupted for less than 3 years, family history (relatives of the&#xD;
             1st degree) Accident major CV before 60.&#xD;
&#xD;
          -  Or whatever the level of risk factors: peripheral artery disease and / or carotid&#xD;
             atherosclerosis, or proteinuria&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Valvular heart disease (severe to moderate valvular ) , hypertrophic , dilated ,&#xD;
             chronic lung&#xD;
&#xD;
          -  History of cardiotoxic chemotherapy&#xD;
&#xD;
          -  Atrioventricular blocks of degree&#xD;
&#xD;
          -  Asthma&#xD;
&#xD;
          -  Recent stroke within a month&#xD;
&#xD;
          -  Bilateral carotid stenosis tight&#xD;
&#xD;
          -  Glaucoma untreated narrow angle&#xD;
&#xD;
          -  Subject to exclusion period (determined by a previous study or in progress)&#xD;
&#xD;
          -  Inability to give informed about information&#xD;
&#xD;
          -  patient under judicial protection&#xD;
&#xD;
          -  patient guardianship or curatorship&#xD;
&#xD;
          -  Current pregnancy (women of childbearing age )&#xD;
&#xD;
          -  Breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samy TALHA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samy TALHA, MD</last_name>
    <email>samy.talha@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emmanuel ANDRES, MD</last_name>
    <email>emmanuel.andres@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Les Hôpitaux Universitaires</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samy TALHA, MD</last_name>
      <email>samy.talha@chu-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Emmanuel ANDRES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <study_first_submitted>August 26, 2016</study_first_submitted>
  <study_first_submitted_qc>August 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2016</study_first_posted>
  <last_update_submitted>December 5, 2016</last_update_submitted>
  <last_update_submitted_qc>December 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

